Company / Operating Income
CANNAPHARMARX, INC. Operating Income History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$3.3M
FY2025
5-year range
-$14.5M / -$3.0M
FY2021-FY2025
Trend
+7.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$16M in FY2019 to -$6,633 in FY2017.
Based on SEC 10-K filings.
-$3M in FY2025.
Improved from -$5M to -$3M over the past 3 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 7.8% year-over-year.
- Peak operating income was recorded in FY2017.
- Lowest operating income in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.3M | +7.8% |
| FY2024 | -$3.6M | +30.3% |
| FY2022 | -$5.2M | -74.1% |
| FY2021 | -$3.0M | +79.3% |
| FY2020 | -$14.5M | +9.3% |
| FY2019 | -$16.0M | -1574.3% |
| FY2018 | -$954.3K | -14287.4% |
| FY2017 | -$6.6K | +99.3% |
| FY2016 | -$1.0M | +91.4% |
| FY2015 | -$11.7M | -193.2% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026